These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29209208)

  • 21. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
    Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
    JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
    Koefoed BG; Feddersen C; Gulløv AL; Petersen P
    Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews.
    Luo J; Song W; Yang G; Xu H; Chen K
    Am J Chin Med; 2015; 43(1):25-43. PubMed ID: 25582415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.
    Kamath S; Blann AD; Chin BS; Lip GY
    J Am Coll Cardiol; 2002 Aug; 40(3):484-90. PubMed ID: 12142115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined low-dose aspirin and warfarin anticoagulant therapy of postoperative atrial fibrillation following mechanical heart valve replacement.
    Wang JT; Dong MF; Song GM; Ma ZS; Ma SJ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Dec; 34(6):902-906. PubMed ID: 25480588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies -CYP2C9 and warfarin as an example.
    Dickinson GL; Lennard MS; Tucker GT; Rostami-Hodjegan A
    Br J Clin Pharmacol; 2007 Jul; 64(1):14-26. PubMed ID: 17298479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
    Feinberg WM; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Hart RG; Bovill EG
    Stroke; 1997 Jun; 28(6):1101-6. PubMed ID: 9183333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing stroke in atrial fibrillation: the SPORTIF programme.
    Lip GY
    Pathophysiol Haemost Thromb; 2005; 34 Suppl 1():25-30. PubMed ID: 15812201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
    Lu W; Chen L; Wang Y; Yao Y; Fu C; Zuo P; Ma G
    Contemp Clin Trials; 2015 Jan; 40():166-71. PubMed ID: 25513965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
    Christersson C; Wallentin L; Andersson U; Alexander JH; Alings M; De Caterina R; Gersh BJ; Granger CB; Halvorsen S; Hanna M; Huber K; Hylek EM; Lopes RD; Oh BH; Siegbahn A
    Heart; 2019 Feb; 105(3):235-242. PubMed ID: 30209126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between warfarin and danshen (Salvia miltiorrhiza).
    Chan TY
    Ann Pharmacother; 2001 Apr; 35(4):501-4. PubMed ID: 11302416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients.
    Yashiro Y; Arimoto T; Hashimoto N; Tamura H; Iwayama T; Ishigaki D; Kumagai Y; Nishiyama S; Takahashi H; Shishido T; Miyamoto T; Watanabe T; Kubota I
    Circ J; 2015; 79(1):61-9. PubMed ID: 25391906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48.
    Zelniker TA; Ruff CT; Wiviott SD; Blanc JJ; Cappato R; Nordio F; Mercuri MF; Lanz H; Antman EM; Braunwald E; Giugliano RP
    Eur Heart J Acute Cardiovasc Care; 2019 Mar; 8(2):176-185. PubMed ID: 30039978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
    Steinberg BA; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Kowey PR; Mahaffey KW; Peterson ED; Piccini JP;
    Am J Cardiol; 2017 May; 119(10):1590-1595. PubMed ID: 28363354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
    Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.
    Lackner TE; Battis GN
    Arch Fam Med; 1995 Dec; 4(12):1017-26. PubMed ID: 7496550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of apixaban compared with warfarin regarding time within the therapeutic range].
    Havasi K
    Orv Hetil; 2014 Feb; 155(5):177-81. PubMed ID: 24463163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.